Clinical Trial Update: A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Trial update reporting safety and pharmacokinetics data from a Phase 1/2 study in participants with rheumatoid arthritis; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Arthritis, Rheumatoid | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-06